Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Esperion Therapeutics Stock Price (Quote) NASDAQ:ESPR
$9.14 ( -1.72% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $9.10 | $13.14 | Friday, 15th Oct 2021 ESPR stock ended at $9.14. This is 1.72% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 4.29% from a day low at $9.10 to a day high of $9.49. |
| 90 days | $9.10 | $18.22 | |
| 52 weeks | $9.10 | $39.50 |
Historical Esperion Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $9.34 | $9.49 | $9.10 | $9.14 | 829 902 |
| 2021-10-14 | $10.02 | $10.09 | $9.21 | $9.30 | 2 674 609 |
| 2021-10-13 | $10.30 | $10.68 | $10.21 | $10.40 | 553 431 |
| 2021-10-12 | $10.19 | $10.59 | $10.16 | $10.30 | 515 586 |
| 2021-10-11 | $10.38 | $10.39 | $10.05 | $10.14 | 343 565 |
| 2021-10-08 | $10.08 | $10.46 | $10.00 | $10.24 | 712 589 |
| 2021-10-07 | $10.13 | $10.59 | $9.99 | $10.15 | 725 997 |
| 2021-10-06 | $10.54 | $10.59 | $10.08 | $10.17 | 770 410 |
| 2021-10-05 | $11.72 | $11.91 | $10.53 | $10.54 | 1 508 184 |
| 2021-10-04 | $11.79 | $11.92 | $11.55 | $11.73 | 1 018 832 |
| 2021-10-01 | $12.00 | $12.15 | $11.69 | $11.92 | 619 657 |
| 2021-09-30 | $12.44 | $12.50 | $11.97 | $12.05 | 390 463 |
| 2021-09-29 | $12.67 | $13.14 | $12.39 | $12.44 | 562 120 |
| 2021-09-28 | $12.38 | $13.07 | $12.21 | $12.62 | 541 078 |
| 2021-09-27 | $11.71 | $12.47 | $11.47 | $12.34 | 695 386 |
| 2021-09-24 | $12.03 | $12.27 | $11.56 | $11.58 | 526 572 |
| 2021-09-23 | $11.82 | $12.15 | $11.51 | $12.10 | 470 591 |
| 2021-09-22 | $12.50 | $13.02 | $11.76 | $11.88 | 1 170 747 |
| 2021-09-21 | $12.47 | $12.93 | $12.35 | $12.92 | 707 946 |
| 2021-09-20 | $12.10 | $12.59 | $11.81 | $12.46 | 859 174 |
| 2021-09-17 | $12.15 | $12.78 | $12.10 | $12.49 | 3 514 354 |
| 2021-09-16 | $11.39 | $12.10 | $11.09 | $12.09 | 937 838 |
| 2021-09-15 | $11.54 | $11.56 | $11.14 | $11.34 | 1 130 176 |
| 2021-09-14 | $11.35 | $12.14 | $10.99 | $11.59 | 1 378 115 |
| 2021-09-13 | $11.82 | $11.85 | $11.12 | $11.38 | 1 333 936 |
| 2021-09-10 | $12.19 | $12.19 | $11.54 | $11.81 | 1 347 922 |
| 2021-09-09 | $11.60 | $12.24 | $11.48 | $12.00 | 825 949 |
| 2021-09-08 | $12.00 | $12.14 | $11.57 | $11.61 | 741 106 |
| 2021-09-07 | $12.77 | $12.77 | $11.86 | $11.97 | 998 662 |
| 2021-09-03 | $12.98 | $13.10 | $12.52 | $12.55 | 675 643 |
| 2021-09-02 | $13.19 | $13.34 | $12.84 | $13.09 | 527 660 |
| 2021-09-01 | $13.16 | $13.33 | $12.89 | $13.17 | 445 693 |
| 2021-08-31 | $12.80 | $13.33 | $12.64 | $13.02 | 475 619 |
| 2021-08-30 | $13.70 | $14.00 | $12.84 | $12.87 | 1 125 434 |
| 2021-08-27 | $13.11 | $13.80 | $13.06 | $13.64 | 634 243 |
| 2021-08-26 | $13.62 | $14.06 | $13.12 | $13.21 | 415 775 |
| 2021-08-25 | $13.61 | $13.84 | $13.28 | $13.65 | 283 335 |
| 2021-08-24 | $13.82 | $14.00 | $13.41 | $13.60 | 267 620 |
| 2021-08-23 | $13.42 | $14.28 | $13.30 | $13.81 | 506 842 |
| 2021-08-20 | $13.29 | $13.58 | $12.90 | $13.17 | 468 669 |
| 2021-08-19 | $13.50 | $13.98 | $13.01 | $13.14 | 623 789 |
| 2021-08-18 | $14.27 | $14.42 | $13.55 | $13.58 | 426 085 |
| 2021-08-17 | $13.84 | $14.40 | $13.60 | $14.26 | 414 973 |
| 2021-08-16 | $13.89 | $14.35 | $13.82 | $13.87 | 463 334 |
| 2021-08-13 | $14.37 | $14.78 | $13.84 | $13.91 | 533 412 |
| 2021-08-12 | $14.08 | $14.56 | $13.81 | $14.52 | 521 904 |
| 2021-08-11 | $14.08 | $14.70 | $14.00 | $14.08 | 438 357 |
| 2021-08-10 | $14.15 | $14.15 | $13.69 | $14.03 | 500 911 |
| 2021-08-09 | $14.24 | $14.68 | $13.92 | $14.03 | 488 161 |
| 2021-08-06 | $15.00 | $15.05 | $13.63 | $14.21 | 854 896 |
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
